Furthermore, we analyzed the association of Wnt7a expression with clinicopathological characteristics and outcome of patients with endometrial carcinomas and evaluated the correlation between Wnt7a expression and the hormone receptor status. This evidence concerns the gene WNT7A and endometrial carcinoma.